WIDE MOAT STOCKS COMPARISON

Checking

 

Stock Comparison

Edwards Lifesciences Corporation vs Medtronic plc

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Edwards Lifesciences Corporation

EW · New York Stock Exchange

Market cap (USD)$51.8B
Gross margin (TTM)78%
Operating margin (TTM)28.1%
Net margin (TTM)15.4%
SectorHealthcare
IndustryMedical devices
CountryUS
Data as of2026-08-23
83/100
Moat score

Weighted across the company's segments.

Full stock profile

Dive deeper into Edwards Lifesciences Corporation's moat claims, evidence, and risks.

View EW analysis

Medtronic plc

MDT · New York Stock Exchange

Market cap (USD)$109.4B
Gross margin (TTM)65%
Operating margin (TTM)18.1%
Net margin (TTM)13.9%
SectorHealthcare
IndustryMedical devices
CountryIE
Data as of2026-08-23
60/100
Moat score

Weighted across the company's segments.

Full stock profile

Dive deeper into Medtronic plc's moat claims, evidence, and risks.

View MDT analysis

Comparison highlights

  • Moat score gap: Edwards Lifesciences Corporation leads (83 / 100 vs 60 / 100 for Medtronic plc).
  • Segment focus: Edwards Lifesciences Corporation has 3 segments (72.3% in Transcatheter Aortic Valve Replacement (TAVR)); Medtronic plc has 4 segments (38.4% in Cardiovascular Portfolio).
  • Moat breadth: Edwards Lifesciences Corporation has 3 moat types across 2 domains; Medtronic plc has 3 across 1.

Primary market context

Edwards Lifesciences Corporation

Transcatheter Aortic Valve Replacement (TAVR)

Market

Transcatheter aortic valve replacement (TAVR) devices

Geography

Global

Customer

Hospitals and structural heart centers

Role

Medical device manufacturer

Revenue share

72.3%

Medtronic plc

Cardiovascular Portfolio

Market

Cardiovascular medical devices (cardiac rhythm management, electrophysiology/ablation, structural heart, coronary & peripheral vascular)

Geography

Global

Customer

Hospitals, cath labs, electrophysiologists, cardiologists, cardiac & vascular surgeons

Role

Device OEM + procedure support + remote monitoring software/services

Revenue share

38.4%

Side-by-side metrics

Edwards Lifesciences Corporation
Medtronic plc
Ticker / Exchange
EW - New York Stock Exchange
MDT - New York Stock Exchange
Market cap (USD)
$51.8B
$109.4B
Gross margin (TTM)
78%
65%
Operating margin (TTM)
28.1%
18.1%
Net margin (TTM)
15.4%
13.9%
Sector
Healthcare
Healthcare
Industry
Medical devices
Medical devices
HQ country
US
IE
Primary segment
Transcatheter Aortic Valve Replacement (TAVR)
Cardiovascular Portfolio
Market structure
Oligopoly
Oligopoly
Market share
60%-73% (estimated)
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
83 / 100
60 / 100
Moat domains
Demand, Legal
Demand
Last update
2026-09-05
2026-09-05

Moat coverage

Shared moat types

Training Org Change Costs

Edwards Lifesciences Corporation strengths

Brand TrustRegulated Standards Pipe

Medtronic plc strengths

Data Workflow LockinInstalled Base Consumables

Segment mix

Edwards Lifesciences Corporation segments

Full profile >

Transcatheter Aortic Valve Replacement (TAVR)

Oligopoly

72.3%

Transcatheter Mitral and Tricuspid Therapies (TMTT)

Competitive

11.4%

Surgical Structural Heart

Oligopoly

16.3%

Medtronic plc segments

Full profile >

Cardiovascular Portfolio

Oligopoly

38.4%

Neuroscience Portfolio

Oligopoly

28.3%

Medical Surgical Portfolio

Competitive

24.2%

Diabetes / consolidated MiniMed

Oligopoly

8.6%

Act on this comparison

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.